248 related articles for article (PubMed ID: 20495479)
1. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
Finkelstein-Shechter T; Gassas A; Mabbott D; Huang A; Bartels U; Tabori U; Janzen L; Hawkins C; Taylor M; Bouffet E
J Pediatr Hematol Oncol; 2010 Jul; 32(5):e182-6. PubMed ID: 20495479
[TBL] [Abstract][Full Text] [Related]
2. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
3. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
Athale UH; Duckworth J; Odame I; Barr R
J Pediatr Hematol Oncol; 2009 Sep; 31(9):651-63. PubMed ID: 19707161
[TBL] [Abstract][Full Text] [Related]
4. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
[TBL] [Abstract][Full Text] [Related]
5. Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Kawaguchi T; Kumabe T; Watanabe M; Tominaga T
Acta Neurochir (Wien); 2004 Sep; 146(9):1033-8; discussion 1038. PubMed ID: 15340816
[TBL] [Abstract][Full Text] [Related]
6. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
7. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
8. Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience).
Chen YW; Wong TT; Ho DM; Huang PI; Chang KP; Shiau CY; Yen SH
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1038-43. PubMed ID: 16406394
[TBL] [Abstract][Full Text] [Related]
9. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
[TBL] [Abstract][Full Text] [Related]
10. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
11. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
Jensen AW; Laack NN; Buckner JC; Schomberg PJ; Wetmore CJ; Brown PD
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1449-56. PubMed ID: 20045266
[TBL] [Abstract][Full Text] [Related]
13. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
[TBL] [Abstract][Full Text] [Related]
15. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors.
De Amorim Bernstein K; Sethi R; Trofimov A; Zeng C; Fullerton B; Yeap BY; Ebb D; Tarbell NJ; Yock TI; MacDonald SM
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):114-20. PubMed ID: 23498870
[TBL] [Abstract][Full Text] [Related]
16. Giant supratentorial atypical teratoid/rhabdoid tumor presentation: a case of a five-year-old child with favorable outcome and review of the literature.
Sasani M; Oktenoglu T; Ozer AF; Sarioglu AC
Pediatr Neurosurg; 2007; 43(2):149-54. PubMed ID: 17337931
[TBL] [Abstract][Full Text] [Related]
17. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
[TBL] [Abstract][Full Text] [Related]
19. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.
Hilden JM; Meerbaum S; Burger P; Finlay J; Janss A; Scheithauer BW; Walter AW; Rorke LB; Biegel JA
J Clin Oncol; 2004 Jul; 22(14):2877-84. PubMed ID: 15254056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
